Systems and Methods for Monitoring Respiratory Therapy Use by Diabetic Patients

The European Patent Office published ResMed Digital Health Inc.'s patent application EP4457828A1, titled 'Systems and Methods for Monitoring the Use of a Respiratory Therapy System by an Individual with Diabetes.' The patent application, filed with search report, covers digital health systems that monitor respiratory therapy usage specifically in diabetic patients, using G16H classifications for health informatics.

Medical device manufacturers and digital health companies developing respiratory therapy products or diabetes monitoring solutions should review the patent claims to assess potential infringement risks or licensing opportunities. The designated states cover all major European markets (AL, AT, BE, BG, CH, DE, DK, ES, FI, FR, GB, GR, HR, HU, IT, NL, NO, PL, PT, SE, SI, SK, etc.), providing broad geographic protection if granted.